Impact of enzyme replacement therapy on survival in adults with Pompe disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of enzyme replacement therapy on survival in adults with Pompe disease ; volume:14 ; number:2 ; day:29 ; month:5 ; year:2013 ; pages:1 ; date:5.2013
BMC musculoskeletal disorders ; 14, Heft 2 (29.5.2013), 1, 5.2013
- Urheber
-
Güngör, Deniz
- Beteiligte Personen und Organisationen
-
Kruijshaar, Michelle
Plug, Iris
D’Agostino, Ralph
Hagemans, Marloes
Reuser, Arnold
van der Ploeg, Ans
SpringerLink (Online service)
- DOI
-
10.1186/1471-2474-14-S2-P15
- URN
-
urn:nbn:de:1111-2016043026611
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Güngör, Deniz
- Kruijshaar, Michelle
- Plug, Iris
- D’Agostino, Ralph
- Hagemans, Marloes
- Reuser, Arnold
- van der Ploeg, Ans
- SpringerLink (Online service)
Ähnliche Objekte (12)
Enzyme replacement therapy and fatigue in adults with Pompe disease
Enzyme replacement therapy (ERT) in pompe disease
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients
The effectiveness of enzyme replacement therapy for juvenile-onset Pompe disease: a systematic review
Enzyme replacement therapy and fatigue in adults with Pompe disease
Enzyme replacement therapy (ERT) in pompe disease
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients
The effectiveness of enzyme replacement therapy for juvenile-onset Pompe disease: a systematic review
Enzyme replacement therapy and fatigue in adults with Pompe disease
Enzyme replacement therapy (ERT) in pompe disease
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study
Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients